Back To: Home : Featured Technology : Reagents/Proteins

CLICK HERE FOR WHAT'S NEW IN:
 
 
 

BioFocus to offer Activiomics’ proteomics services
September 2012
SHARING OPTIONS:

SAFFRON WALDEN, United Kingdom—BioFocus and Activiomics have established a strategic alliance under which BioFocus will offer Activiomics' proteomics services to its customers for improved identification of targets for drug discovery and diagnostics biomarkers. Activiomics' proprietary technology, Targeted In-depth QUAntification of cell Signaling (TIQUAS), offers insights into the proteins or pathways that are activated following cell signaling events, and has potential in areas such as cancer, inflammation and metabolic disease. By using mass spectrometry-based techniques, TIQUAS can quantify thousands of phosphorylation sites from a cell or tissue extract.  
 
"Proteomics analysis, in particular phosphoproteomics, is becoming ever more important in drug discovery programs. By partnering with Activiomics, BioFocus extends its offering of high- quality scientific expertise into this newly emerging area," said Chris Newton, senior vice president of Galapagos Services and managing director of BioFocus.

Back


PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.